- recruitingTherapeutic exploratory (Phase II)
Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.- The CARAMEL Study
This study, called CARAMEL, is looking at whether a cannabis-related medicine (CBD) can help people reduce their drinking when they have alcohol use disorder. It also checks if CBD can affect how alcohol impacts the brain and liver. It's a key step in understanding new ways to help.
France - active not recruitingPHASE4
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
This study looks at whether a medicine called semaglutide (Wegovy®), along with healthy eating and exercise, can help people who have gained weight from certain mental health medications. It aims to reduce weight gain linked to antipsychotic treatment.
United Kingdom - recruiting
Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
This study looks at how mental health conditions affect people recovering from addiction in hospital. We want to understand which conditions increase the risk of going back to using substances, and how best to help prevent this by improving care and diagnosis.
France